These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 27144279)

  • 41. Comparison of the clinical efficacy between tigecycline plus extended-infusion imipenem and sulbactam plus imipenem against ventilator-associated pneumonia with pneumonic extensively drug-resistant Acinetobacter baumannii bacteremia, and correlation of clinical efficacy with in vitro synergy tests.
    Jean SS; Hsieh TC; Hsu CW; Lee WS; Bai KJ; Lam C
    J Microbiol Immunol Infect; 2016 Dec; 49(6):924-933. PubMed ID: 26341302
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Safety and efficacy of intravenous tigecycline in subjects with secondary bacteremia: pooled results from 8 phase III clinical trials.
    Gardiner D; Dukart G; Cooper A; Babinchak T
    Clin Infect Dis; 2010 Jan; 50(2):229-38. PubMed ID: 20025527
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tigecycline treatment experience against multidrug-resistant Acinetobacter baumannii infections: a systematic review and meta-analysis.
    Ni W; Han Y; Zhao J; Wei C; Cui J; Wang R; Liu Y
    Int J Antimicrob Agents; 2016 Feb; 47(2):107-16. PubMed ID: 26742726
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacokinetic and pharmacodynamic evaluation of tigecycline.
    Giamarellou H; Poulakou G
    Expert Opin Drug Metab Toxicol; 2011 Nov; 7(11):1459-70. PubMed ID: 21958044
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Tigecycline: antimicrobial action, chemotherapeutic efficacy and adverse reactions].
    Nikitin AV
    Antibiot Khimioter; 2009; 54(1-2):63-6. PubMed ID: 19499721
    [No Abstract]   [Full Text] [Related]  

  • 46. Tigecycline Therapy for Nosocomial Pneumonia due to Carbapenem-Resistant Gram-Negative Bacteria in Critically Ill Patients Who Received Inappropriate Initial Antibiotic Treatment: A Retrospective Case Study.
    Wu X; Zhu Y; Chen Q; Gong L; Lin J; Lv D; Feng J
    Biomed Res Int; 2016; 2016():8395268. PubMed ID: 28044137
    [No Abstract]   [Full Text] [Related]  

  • 47. All-cause mortality imbalance in the tigecycline phase 3 and 4 clinical trials.
    McGovern PC; Wible M; El-Tahtawy A; Biswas P; Meyer RD
    Int J Antimicrob Agents; 2013 May; 41(5):463-7. PubMed ID: 23537581
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The glycylcyclines: a comparative review with the tetracyclines.
    Zhanel GG; Homenuik K; Nichol K; Noreddin A; Vercaigne L; Embil J; Gin A; Karlowsky JA; Hoban DJ
    Drugs; 2004; 64(1):63-88. PubMed ID: 14723559
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparable Efficacy of Tigecycline versus Colistin Therapy for Multidrug-Resistant and Extensively Drug-Resistant Acinetobacter baumannii Pneumonia in Critically Ill Patients.
    Kim WY; Moon JY; Huh JW; Choi SH; Lim CM; Koh Y; Chong YP; Hong SB
    PLoS One; 2016; 11(3):e0150642. PubMed ID: 26934182
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Tigecycline: a new antibiotic in ongoing clinical development].
    Stahl JP
    Med Mal Infect; 2005 Feb; 35(2):62-7. PubMed ID: 15780894
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Integrated results of 2 phase 3 studies comparing tigecycline and levofloxacin in community-acquired pneumonia.
    Tanaseanu C; Bergallo C; Teglia O; Jasovich A; Oliva ME; Dukart G; Dartois N; Cooper CA; Gandjini H; Mallick R; ;
    Diagn Microbiol Infect Dis; 2008 Jul; 61(3):329-38. PubMed ID: 18508226
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tigecycline: a critical update.
    Shakil S; Akram M; Khan AU
    J Chemother; 2008 Aug; 20(4):411-9. PubMed ID: 18676218
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical experience of tigecycline treatment in infections caused by extensively drug-resistant Acinetobacter spp.
    Moon SY; Peck KR; Chang HH; Kim SW; Heo ST; Son JS; Ryu SY; Moon C; Jung SI; Shin SY; Lee JA; Joung MK; Chung DR; Kang CI; Song JH
    Microb Drug Resist; 2012 Dec; 18(6):562-6. PubMed ID: 22775562
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tigecycline.
    Frampton JE; Curran MP
    Drugs; 2005; 65(18):2623-35; discussion 2636-7. PubMed ID: 16392879
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The efficacy and safety of tigecycline for the treatment of complicated intra-abdominal infections: analysis of pooled clinical trial data.
    Babinchak T; Ellis-Grosse E; Dartois N; Rose GM; Loh E; ;
    Clin Infect Dis; 2005 Sep; 41 Suppl 5():S354-67. PubMed ID: 16080073
    [TBL] [Abstract][Full Text] [Related]  

  • 56. New antibiotic approved for MRSA.
    Senior K
    Lancet Infect Dis; 2005 Aug; 5(8):474. PubMed ID: 16094734
    [No Abstract]   [Full Text] [Related]  

  • 57. Overview of tigecycline efficacy and safety in the treatment of complicated skin and skin structure infections - a European perspective.
    Teras J; Gardovskis J; Vaasna T; Kupcs U; Pupelis G; Dukart G; Dartois N; Jouve S; Cooper A;
    J Chemother; 2008 Oct; 20 Suppl 1():20-7. PubMed ID: 19036671
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacokinetics, pharmacodynamics, safety and tolerability of tigecycline.
    Rello J
    J Chemother; 2005 Aug; 17 Suppl 1():12-22. PubMed ID: 16285354
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tigecycline-induced acute pancreatitis: case report and literature review.
    Hung WY; Kogelman L; Volpe G; Iafrati M; Davidson L
    Int J Antimicrob Agents; 2009 Nov; 34(5):486-9. PubMed ID: 19540093
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A multicenter trial of the efficacy and safety of tigecycline versus imipenem/cilastatin in patients with complicated intra-abdominal infections [Study ID Numbers: 3074A1-301-WW; ClinicalTrials.gov Identifier: NCT00081744].
    Oliva ME; Rekha A; Yellin A; Pasternak J; Campos M; Rose GM; Babinchak T; Ellis-Grosse EJ; Loh E;
    BMC Infect Dis; 2005 Oct; 5():88. PubMed ID: 16236177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.